Survival benefit from first docetaxel treatment for cabazitaxel plus prednisone compared with mitoxantrone plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in the TROPIC trial.

Sartor A. O., Oudard S., Ozguroglu M., Hansen S., Machiels J. H., Shen L., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.29, no.15, 2011 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Volume: 29 Issue: 15
• Publication Date: 2011
• Doi Number: 10.1200/jco.2011.29.15_suppl.4525
• Journal Name: JOURNAL OF CLINICAL ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Istanbul University-Cerrahpasa Affiliated: No